Mitoquinone mesylate as post-exposure prophylaxis against SARS-CoV-2 infection in humans: an exploratory single center pragmatic open label non-randomized pilot clinical trial with matched controls

By sjmartinez • March 12, 2024

Chen K, Jackson NJ, Kelesidis T. Mitoquinone mesylate as post-exposure prophylaxis against SARS-CoV-2 infection in humans: an exploratory single center pragmatic open label non-randomized pilot clinical trial with matched controls. EBioMedicine. 2024 Mar 7:105042. doi: 10.1016/j.ebiom.2024.105042. Epub ahead of print. PMID: 38471990.

Tags: Antiviral treatment, clinical trials, covid-19, General Internal Medicine, Mitochondrial antioxidants, Post-exposure prophylaxis, Publications, SARS-CoV-2 infection, Translational research

Correction: A workshop considering genetic research and data collection with American Indian and Alaska Native people outside of tribal jurisdiction

Beans JA, Blanchard J, Hiratsuka V, Helton T, Carroll S, Dillard D, Orr R, Gachupin FC, Hull S, Haring RC, Garrison NA, Saukeah B, Tsosie[...]

Psychological factors as mediators of the effectiveness of telehealth mindfulness-based interventions for pain and pain-related conditions

Taylor SL, Calvert C, Haley AC, Evans R, Adamowicz J, Allen KD, Bronfort G, Cross LJS, Goldsmith ES, Grant A, Leininger B, Matthias MS, Serpa[...]

Maintaining control: challenges and facilitators to medication adherence among young adults with HIV and recent criminal legal system experience or high risk for system involvement

Mungo L, Harawa NT, Seiden D, McAvoy-Banerjea J, Wang L, Brewer RA, Belzer M. Maintaining control: challenges and facilitators to medication adherence among young adults[...]